Objectives: The nuclear receptor superfamily is a potential target for the development of new treatments for obesity and metabolic diseases. Increasing evidence has pointed towards the retinoic acid-related orphan receptor-alpha (RORa) as an important nuclear receptor involved in several biological processes. RORa full body knockout mice display improved metabolic phenotypes on both chow and high fat (60% fat, 20% carbohydrate) diets, but also have severe behavioral abnormalities. Here we investigated the effect of hepatic RORa by generating mice with liverspecific RORa deletion to elucidate the role of this nuclear receptor on host metabolism. Methods: 8 week-old mice with liver-specific RORa deletion and littermate controls were fed either chow or western-style diets (40% fat, 40% carbohydrate) for 12 weeks. Metabolic phenotyping was performed at the end of the dietary intervention.
INTRODUCTION
The incidence of obesity and metabolic associated disorders, such as cardiovascular diseases, type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD), increase worldwide [1e3]. Furthermore, there are no effective long-term non-surgical treatments for obesity and metabolic associated disorders [4] . However, accumulating evidence points towards nuclear receptors (NRs) as potential molecular treatment targets [5, 6] . The NRs superfamily comprises 48 transcription factors in humans, which are involved in the regulation of a wide range of physiologic and pathophysiologic processes (i.e. development, circadian rhythm, response to steroid hormones, inflammation, obesity, diabetes, NAFLD, and cancer) [7e10].
The retinoic acid-related orphan receptor a (RORa; NR1F1) is a NR that has been implicated in the regulation of a wide variety of metabolic pathways, including lipid, glucose and steroid metabolism [11e13] . The initial indications that RORa can affect metabolic processes originate mainly from a natural occurring mutant mouse, the Staggerer mouse, which results in a loss of function [14] .
Staggerer mice are protected against diet-induced obesity and associated complications (i.e., adipose tissue inflammation, NAFLD, and impaired glucose metabolism), but also have cerebral phenotypes including impaired locomotion [15, 16] . However, activation of RORa with synthetic ligands also improves NAFLD by reducing hepatic oxidative stress and inflammation suggesting a potential beneficial role of RORa activation on obesity and metabolic diseases [17e19] . In order to elucidate the role of RORa in obesity and metabolic diseases, tissue specific knockout models have recently been developed. Liver-specific ablation of RORa deteriorates metabolic profile in terms of adiposity, liver steatosis, inflammation and hepatic insulin resistance, when mice were fed a high fat diet (60% of energy from fat and 20% from carbohydrates) [20, 21] . These findings suggest a central role of RORa in the regulation of hepatic lipid and glucose metabolism. To further extend and validate the role of RORa on glucose and lipid metabolism, we generated an independent liver-specific RORa deficient strain that was metabolically phenotyped on both chow and western-style diet (WSD; 40% of energy from fat and 40% from carbohydrate and 20% protein). 1 
MATERIALS AND METHODS

Mice experiments
Mice harbouring loxP sequences flanking exon 3, the first common exon coding for both isoform 1 and 4, were generated ( Figure 1A) . Deletion of the 86 bp exon 3 led to a frame shift resulting in a premature stop codon. Potential translated truncated proteins would be composed of 88 and 32 amino acids instead of 523 and 467 for isoform, 1 and 4 respectively. No functional domain would be present on these putative proteins. Generation of the strain was completed by homologous recombination in C57BL/6J embryonic stem cells followed by microinjection into C57BL/6J blastocysts. The resulting new-borns were crossed with C57BL/6 Flp delete mice to allow the excision of the neomycin selection cassette. Albumin-Cre mice were purchased from The Jackson Laboratory. Cre efficacy and specificity towards hepatocytes was confirmed by breading the mice with ROSA mT/mG mice (data not shown). 
Analysis of liver lipids content
Lipids were extracted using the BUME method [23] . The cholesteryl esters, triglycerides and free cholesterol were analyzed using straight phase HPLC coupled to evaporative light scattering detection according to previous work [24] . Briefly, the extract was evaporated under nitrogen and reconstituted in 500 ml heptane:isopropanol [9:1] . Cholesteryl esters, triglycerides, and free cholesterol were separated using straight-phase HPLC (Sunfire 2.1 Â 100 mm, Waters) coupled to an evaporative light-scattering detector (PL-ELS 1000, Polymer Laboratories), as described previously [24] . Quantification was made using external standards (Larodan Fine Chemicals).
Primary hepatocytes
Primary hepatocytes were isolated from RORa LKO and RORa fl/fl littermates mice by digesting liver with perfusion of collagenase type IV, as described previously [25] . After perfusion, 16 Â 10 5 cells were plated on collagencoated 60 mm dishes in Dulbecco's modified Eagle's medium (DMEM)/ F12 (Thermo Fisher) supplemented with fetal bovine serum (Thermo Fisher), penicillin/streptomycin, and 100 nM dexamethasone (Sigma Aldrich). After 4 h, the medium was changed to DMEM/F12 containing penicillin/streptomycin and then cells were harvested after 18h.
Preparation of protein extracts and immunoblotting
RORa deletion in the liver was evaluated by extracting proteins from the snap-frozen liver or primary cells with lysis buffer, as described previously [26] and immunoblotting with anti-RORa (Abcam, ab60134, 1:300 dilution), GADPH (Cell Signaling #2118, 1:1000 dilution), and anti-actin (Cell Signaling #4970, 1:1000 dilution) antibody.
Quantitative RT-PCR
Total RNA was isolated using RNeasy kit with DNase treatment (Qiagen) and cDNA templates were generated using the high-capacity cDNA reverse transcription kit using random hexamers (Applied Biosystems). qRT-PCR assays were performed in 10 ml reactions with SYBR Green Master Mix buffer (Thermo Scientific). Gene expression data were normalized to the ribosomal protein L32. Primer sequences used are listed in Supplementary Table 1 (SigmaeAldrich).
Statistical analysis
Data are presented as mean -SEM. Analyses between groups were performed by Student's t-test using GraphPad Prism 7 software.
RESULTS
Generation of mice with a hepatocyte specific RORa deletion
We generated mice with a hepatocyte specific Rora deletion of by introducing loxP sites flanking exon 3 of the Rora allele and crossing them with mice expressing Cre under the albumin promotor ( Figure 1A and Supplementary Fig. 1A ).
Analyses of Rora expression by qRT-PCR in the liver, ileum, white adipose tissue (WAT), and brain, as well as RORa protein levels by Western blotting, confirmed a selective and specific liver deletion in RORa LKO mice compared to littermate RORa fl/fl mice (Figure 1BeC ).
Liver RT-qPCR analysis showed that there was a trend (p ¼ 0.057) towards a compensatory increased expression of Rorc by the selective and specific liver RORa deletion ( Supplementary Fig. 1B) . Rorb was not detectable in the livers (data not shown). Moreover, the expression of Rev-erba, one of the known RORs target genes, was reduced by the selective and specific liver RORa deletion ( Supplementary Fig. 1B ). The expression of other RORs target genes (i.e. Rev-erbb, Pparg, Cyp7b1, and Lxra) was not affected by the selective and specific liver RORa deletion ( Supplementary Fig. 1B (Figure 2A ), whole body adiposity determined by MRI ( Figure 2B ) or liver, WAT, spleen and cecum weights ( Figure 2C ). Liver RT-qPCR analysis as well as liver lipid measurements did not reveal any differences in lipid metabolism genes nor in cholesterol, cholesteryl ester or triglyceride levels between RORa LKO and RORa fl/fl littermates ( Figure 2D and Supplementary Fig. 2 ).
Fasting glucose and insulin levels as well as glucose levels during glucose-, insulin-, and pyruvate tolerance tests did not demonstrate any differences between RORa LKO and RORa fl/fl littermates (Figure 2EeI ). Similar findings where obtained for female mice (see Supplementary Fig. 3 ). Taken together, our findings suggest that hepatocyte RORa deletion does not affect glucose and lipid metabolism on chow diet neither in males nor in females.
3.3. RORa hepatic deletion does not affect glucose and lipid metabolism in mice fed Western style diet To further study the effect of RORa on metabolic associated disorders, we fed 8-week-old RORa LKO and littermate RORa fl/fl male mice with a WSD for 12 weeks. We did not observe any significant differences in weight gain ( Figure 3A) , whole body adiposity measured with MRI ( Figure 3B ) or liver, WAT, spleen or cecum weights ( Figure 3C ) suggesting that RORa does not affect diet-induced obesity. Liver RT-qPCR analysis as well as liver lipid measurements did not reveal any differences in in lipid metabolism genes nor in cholesterol, cholesteryl esters or triglyceride levels between RORa LKO and RORa fl/fl littermates ( Figure 3D and Supplementary Fig. 4 ). Next, we assessed whether RORa contributes to glucose metabolism during WSD by analyzing fasting glucose and insulin levels as well as performing glucose-, insulin-and pyruvate tolerance tests. We did not observe any differences between RORa LKO and RORa fl/fl littermates (Figure 2EeI ). Similar findings were obtained when we used female mice (see Supplementary Fig. 5 ). Taken together, our findings suggest that a hepatocyte RORa deletion does not affect glucose and lipids metabolism on WSD in both males and females.
DISCUSSION
NRs have been shown to play a crucial role in the regulation of glucose and lipid metabolism. Evidences from the RORa whole body knockout (Staggerer) mice have pointed towards RORa as a potential molecular target for the treatment of metabolic diseases [14e16]. However, the improved metabolic phenotype of Staggerer mice is highly affected by the staggering phenotype induced by the cerebellum RORa deletion [14, 15] , thus it is difficult to evaluate the role of RORa in metabolic active tissues, such as the liver. Here, by generating a liver specific RORa knockout mouse model, we did not detect any effects of RORa liver deletion on glucose or lipids metabolism on chow diet or after a WSD exposure. Our data are in contrast with recent published data that showed that liver-specific ablation of RORa dramatically worsens metabolic profiles in mice eg. increased adiposity, liver fat accumulation, inflammation, and hepatic insulin resistance, when mice are fed a high fat diet [20, 21] . Several factors should be taken into account when comparing the discrepancy between the distinct phenotype reported by other groups and our present study. First, we targeted RORa exon 3 while the Cre-lox system used by others targeted exon 4 and 4e5, leaving the exon 3 that encodes the beginning of the DNA binding domain. Although the stability of potentially produced recombinant proteins, which in our experience usually is low, we cannot exclude that the generation of different truncated proteins containing a portion of the DNA binding domain may explain some of the divergent results between the studies. Importantly, we demonstrated an almost complete elimination of RORa in hepatocytes similar to other groups and also a significant effect on some of the known RORa target genes [20, 21, 27, 28] . Second, we challenged our mice with WSD while other reports used HFD. Importantly, it has been well-documented that, despite containing fewer calories, WSD induces more pronounced steatosis and liver inflammation compared with HFD [29, 30] . Thus, it may be plausible that in our model, the effect of WSD on steatosis and inflammation overwhelms the effect of RORa liver deletion. In support to our findings Zhang et al. recently reported that the single knockout of RORa or RORg in hepatocyte has almost no effect on liver gene expression while the double deletion of both RORa and RORg in hepatocytes has a substantial impact on gene expression profiles, increases lipogenesis and therefore predisposes to HFD-induced steatosis [31] . RORa and RORg bind to the same response element and are both highly expressed in liver. Thus, deletion of only one of them may not be sufficient to induce a metabolic phenotype due to their functional redundancy. In our experimental model upon deletion of RORa, we observed a trend towards increased Rorc expression, which may be a compensation for the lack of RORa activity. Taken together, it is thus likely that double targeting of RORa and RORg may be required for achieving maximum effect. Moreover, it is known that RORa is a clock gene involved in circadian rhythm regulation [31, 32] . In an attempt to reduce experimental variation all metabolic phenotyping was performed at the same time of the day. Thus we cannot exclude that the discrepancy between our data and previous published data may be due to differences in experimental set up such as time of analyses.
CONCLUSIONS
In conclusion, our data show that the deletion of RORa in the liver does not affect glucose or lipid metabolism during WSD in mice. Further studies testing the role of liver RORa or the double RORa and RORg deletion in different dietary settings are needed to further elucidate the role of RORa on obesity and metabolic associated disorders.
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